ClinicalTrials.Veeva

Menu

The Effectiveness of Titanium-Prepared Platelet-Rich Fibrin on Angiogenic Biomarkers in Gingival Crevicular Fluid (T-PRF)

K

Kırıkkale University

Status

Completed

Conditions

Chronic Periodontitis
Intrabony Periodontal Defect

Treatments

Procedure: Allograft
Procedure: T-PRF

Study type

Interventional

Funder types

Other

Identifiers

NCT02692079
2014/18

Details and patient eligibility

About

This study investigates the effect of titanium-prepared platelet-rich fibrin (T-PRF) treatment on the angiogenic biomarkers in gingival crevicular fluid (GCF) in infrabony defects of patients with chronic periodontitis. In each patient, the infrabony defect of one side of arch was designated as control group (allograft), while the infrabony defect on the contralateral side of same arch was designated as test group (allograft+T-PRF).

Full description

Platelets are the cells initiating the wound healing and also supporting it by secreting various growth factors actively. These growth factors released by platelets act the increase of connective tissue healing, bone regeneration and repair, fibroblast mitogenesis, wound angiogenesis and the activation of macrophages by stimulating cell proliferation signals.

Titanium-prepared, platelet-rich fibrin (T-PRF), is a new platelet concentrate, is formed in titanium tubes may be more efficient to activate platelets in comparison with glass tubes.The titanium tubes is utilized to refrain any inverse effects of glass tubes and also silica.

Enrollment

25 patients

Sex

All

Ages

26 to 59 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical Diagnosis of Chronic Periodontitis
  • The presence of two or three-wall intrabony defects≥3 mm deep along with an interproximal probing depth ≥5 mm after non-surgical periodontal therapy

Exclusion criteria

  • Systemic illnesses
  • Any medications known to affect the outcomes of periodontal surgery
  • Pregnancy and lactation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

25 participants in 2 patient groups

T-PRF+Allograft
Experimental group
Description:
The defects were debrided and root planed with ultrasonic instrumentation and area-specific curets. All sites were washed with sterile salin solution and bleeding control was performed. Test group sites were treated with T-PRF+allograft
Treatment:
Procedure: Allograft
Procedure: T-PRF
Allograft
Experimental group
Description:
The defects were debrided and root planed with ultrasonic instrumentation and area-specific curets. All sites were washed with sterile salin solution and bleeding control was performed. Control group sites were treated with only allograft
Treatment:
Procedure: Allograft

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems